About
Transmutex, founded in 2019 in Geneva, Switzerland, develops nuclear energy technology for industrial and medical applications.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Company· 12
Investor· 10
Founders / team· 1
Funding history
- 2024-02New funding round$23M
Investors · At One Ventures, Tiny Supercomputer Investment Company, House Of Ventures, FONGIT, AlleyCorp, Union Square Ventures, Verve Ventures, HCVC, Presight Capital, Steel AtlasSource · SVTR Weekly #038
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Transmutex
Nuclear technology for industrial and medical uses
Undisclosed · $23M · 2024-02
$23M
United States
BusinessLatest roundTotal raisedDate- Plenful
AI-driven workflow automation platform that simplifies administrative tasks for pharmacies and healthcare providers
Series B · $59M · 2025-05
$59M - Bunkerhill Health
AI agent platform Carebricks for hospitals and health systems, turning their own clinical and operational ideas into production AI agents for imaging review, patient follow-up identification, prior authorization and registry management automation.
Series B · $25M · 2026-07
$25M - Tokaido Health
Uses AI and behavioral incentives to help employers, health plans and patients choose lower-cost, better prescription drugs and medical services
Seed · $25M · 2026-05
$25M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Connecticut Innovations
6 Life Sciences deals in the last 24 months · 1 in Switzerland
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.